Brief: Egetis Therapeutics FY Adjusted EPS SEK -1.1

Egetis Therapeutics AB (publ)

26/02/2025 06:00

Feb 26 (Reuters) - Egetis Therapeutics FY net income SEK -343.6 million.

FY revenue SEK 46.1 million vs. IBES estimate SEK 55.6 million